Table 1. The Effects of DYN 1–17 and Its N-terminal Biotransformation Fragments on LPS-stimulated NF-κB/p65 nuclear translocation.
Treatment | Inhibition of NF-κB/p65 nuclear translocation | Modulation of IL-1β release | Modulation of TNF-α release | |||||
---|---|---|---|---|---|---|---|---|
10 nM | 1 μM | 10 pM | 1 nM | 0.1 μM | 10 pM | 1 nM | 0.1 μM | |
DYN 1–17 | √* | √ | ↓ | ↓ | ↓* | ↔ | ↔ | ↔ |
DYN 1–6 | √* | √ | ↑ | ↑* | ↑ | ↔ | ↑ | ↑* |
DYN 1–7 | √* | X | ↓* | ↓ | ↓ | ↓* | ↓* | ↓ |
DYN 1–9 | √* | √ | ↔ | ↔ | ↔ | ↔ | ↔ | ↔ |
DYN 1–10 | √ | √ | ↔ | ↔ | ↔ | ↔ | ↔ | ↔ |
DYN 1–11 | √ | √ | ↔ | ↔ | ↔ | ↔ | ↔ | ↔ |
U50,488H | √* | X | ↓* | ↔ | ↔ | ↓* | ↔ | ↔ |
*significant antagonism with ML-190, p ≤ 0.05
↓ = inhibit, ↑ = enhance, ↔ = no changes, √ = yes, X = no